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Background: The effects of paclitaxel-eluting balloon (PEB) on ﬂow limiting intact
plaques, healing processes and plaque remodeling at long term are not known. Aim of
this exploratory study was to assess the long-term coronary arterial response to DEB
using serial VH-IVUS.
Methods: Patients with de novo signiﬁcant A/B lesion type in vessels with diameter >
2,5mm and £ 3,5mm were enrolled. Major exclusion criteria were in-stent restenosis
and STEMI patients. Lesion of interest was predilated and then treated with PEB
(Dior, Eurocor) with a RVD/balloon diameter ratio of 1. Patients who received bail-
out stenting were excluded. VH-IVUS data were acquired before the predilation and at
4-month FU. Primary objective was to assess the change in % atheroma volume
(PAV) and necrotic core (NC) volume from baseline to FU in the entire lesion.
Secondary objectives were change from baseline in: VH plaque type, lumen area (LA)
and plaque burden at the MLA site.
Results: A total of 23 were screened, but eventually18 patients were enrolled in the
study. Mostly, the target vessel was RCA (66.7% of cases). Mean DEB diameter and
length were 30.41 and 19.33.9 respectively. Serial IVUS data at baseline and at
4-month FU are reported in Table 1. In the entire lesion, PAV and NC volume did not
change signiﬁcantly, while at the MLA site, LA increased and plaque burden
diminished as a result of a signiﬁcant increase in EEM area. Remodeling index
changed from 0.930.17 to 1.090.17 (p 0.00019). VH Thin Capped Fibroatheromas
(TCFAs) signiﬁcantly decreased from 7 to 2 changing into more stable plaque
phenotypes (ThCFA and PIT).Baseline (n=18)
4-month follow-up
(n=18) P value
Lumen area (mm2) 2.50.7 3.61.2 0.0038
EEM area (mm2) 10.64.0 12.74.6 0.0017
Plaque burden (%) 74.98.1 69.98.3 0.0283
Remodeling index 0.930.17 1.090.17 0.0019
Lesion length (mm) 9.83.9 10.53.2 0.1860
PAV (%) 62.29.0 59.58.8 0.1256
NC (%) 21.37.2 22.07.8 0.7035
FF (%) 10.04.1 9.13.7 0.4856
FT (%) 62.09.8 60.810.9 0.5048
DC (%) 7.16.0 8.07.7 0.4975
TCFA, n (%) 7 (38.8) 2 (11.1)
ThCFA, n (%) 8 (44.4) 13 (72.2)










SConclusions: PCI with DEB was not associated with a signiﬁcant change in PAV and
NC volume over time. However, TCFAs changed their phenotype into a more stable
looking one. This hypothesis generating study might serve as a basis for exploring
further the plaque sealing concept in a larger study.JACC Vol 62/18/Suppl B j October 27–November 1, 2013 j TCT AbstrTCT-591
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Background: We hypothesized that biodegradable polymer siroimus-eluting stents
(BP-SES) might enhance vascular healing as compared to permanent polymer ever-
olimus-eluting stents (PP-EES). Accordingly we compared the healing patterns of BP-
SES (Osiro) with PP-EES (Xience) using optical coherence tomography (OCT).
Methods: A total of 60 patients undergoing coronary intervention for de novo
stenoses were randomly assigned to BP-SES or PP-EES in 1:1 allocation. Tissue
coverage, stent apposition and neointimal maturity were assessed using OCT at 6-8
months.
Results: Both stents showed marked heterogeneity in vascular healing. After
adjustment for strut-level clustering with a mixed linear model approach, there were
no statistical differences in the rates of uncovered struts between BP-SES and PP-EES
(8.3% [95%CI: 0.6-56.8%] vs. 3.9% [95%CI: 0-81.7%] in PP-EES, p¼.41, Figure A).
A total of 0.1% of struts were malapposed in BP-SES group and 0.4% of struts in PP-
EES group (p¼.42). In patient-level analysis, 2 patients in BP-SES group versus 3 in
PP-EES group had >30% of uncovered struts, respectively (p¼.52). Neointimal
volume obstruction was 8.8% [5.8-14.0] in BP-SES versus 11.2% [8.0-23.5] in PP-
EES (p¼.15, Figure B).
Conclusions: No signiﬁcant differences in tissue coverage were detected by OCT
between BP-SES and PP-EES. Marked heterogeneity of healing was observed in both
groups.TCT-592
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Background: Fully bioresorbable scaffolds (BRS) are a novel approach of treatment
for coronary narrowing that provides transient vessel support with drug delivery
capability without the long-term limitations of metallic drug-eluting stents. However,
a potential drawback of the bioresorbable scaffold is the potential for disruption of the
strut network when over-expanded. Conversely, the structural discontinuity of the
polymeric struts at a late stage is a biologically programmed fate of the scaffold during
the course of bioresorption.
Methods: The ABSORB Cohort B trial is a multicentre single-arm trial assessing the
safety and performance of the Absorb BVS (second generation, Abbott Vascular,acts/POSTER/Intravascular Imaging and PCI B179







SSanta Clara, USA) in the treatment of 101 patients with de novo native coronary artery
lesions. The current analysis included 51 patients with 143 OCT pullbacks (Baseline:
52, 6 month: 25, 1 year: 22, 2 year: 26, 3 year: 18) who underwent OCT at baseline
and follow-up. The presence of acute disruption or late discontinuities was diagnosed
by the presence on OCT of stacked, overhung struts or isolated intraluminal struts
disconnected from the expected circularity of the device.
Results: Out of 51 patients with OCT imaging post-procedure, acute scaffold
disruption was observed in 2 patients (3.9%). One patient had a target lesion revas-
cularization presumably related to the disruption. Out of 49 patients without acute
disruption, late discontinuities were observed in 21 patients. There were no major
adverse cardiac events associated with this ﬁnding except for one patient who had
a non-ischemia driven target lesion revascularization.
Conclusions: Acute scaffold disruption is a rare iatrogenic phenomenon that has been
anecdotally associated with anginal symptoms, whereas late strut discontinuity is
observed in approximately 40% of patients and could be viewed as a serendipitous
OCT ﬁnding of a normal bioresorption process without clinical implications.
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Background: During the ﬁrst 3 years after implantation of an everolimus-eluting
poly-l-lactic-acid (PLLA) scaffold (Absorb BVS, Abbott Vascular), the polymeric
struts are progressively hydrolyzed and subsequently replaced by proteoglycan.
Eventually, the provisional matrix becomes cellularized by smooth　muscle cell or
connective tissue. Previous preclinical studies demonstrated that Optical Coherence
Tomography (OCT) by visual assessment is unable to distinguish polylactide from
proteoglycan, and therefore is not sensitive enough to investigate the process of
bioresorption. Light intensity assessment of strut on OCT might be a sophisticated
method to quantify the phenomenon of cellularization. The aim of this study was to
test this novel quantitative method on serial human OCT.
Methods: In the ABSORB Cohort B2 trial, 17 patients underwent serial frequency-
domain OCT post procedure, at 1year and at 3 years. Corresponding struts in corre-
sponding cross-sections at different times were detected by using anatomical land-
marks. The region of interest (ROI) encompassing the corresponding struts was
selected visually; two different intensity assessments were performed: one was "Area
assessment" for measuring the mean intensity value of the strut area line and the other
was "Line assessment" for measuring the peak intensity value along a single scan line.
Results: A total of 172 corresponding struts were sequentially analyzed. The results
are shown in the table. (Figure)Conclusions: The mean and peak light intensity of corresponding struts increased
steadily from baseline to 3 years, suggesting that this quantitative method of OCT
assessment might be valuable for monitoring the resorption process of polymeric
bioresorbable scaffolds.B180 JACC Vol 62/18/Suppl B j October 27–NoveTCT-594
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Background: Different stent material/design and post-dilatation strategies can impact
on ﬁnal stent expansion. The aim of this study was to evaluate the acute recoil of the
latest-generation coronary stents compared with conventional stents.
Methods: Optical coherence tomography (OCT) imaging was performed on 3 latest-
generation (LG) stents (Multi-Link 8, Integrity and Element), 2 conventional cobalt
chromium (CC) stents (Driver and Vision) and 3 conventional stainless steel (SS)
stents (Select, Liberté and S-Stent) (F3.0 mm, N¼6 each) during and after balloon
inﬂation in a silicone-tube bench model. After nominal-pressure deployment (15 sec),
a single long (30 sec) vs. multiple short (10 sec x 3 times) post-dilatations were
performed using a non-compliant balloon (3.25 mm, 20 atm).
Results: Stent areas during deployment signiﬁcantly varied among 3 groups (LG 6.5,
CC 7.1, SS 6.1 mm2, p<0.01). Recoil after deﬂation in LG was similar to SS, but
smaller than CC (-8.1%, -8.2%, -12.1%, p<0.01). Signiﬁcant recoil was also observed
after post-dilatation, regardless of stent types and inﬂation strategies. Overall, multiple
short inﬂations achieved greater ﬁnal stent areas than single long inﬂation (Figure).
Final stent area in LG was similar to CC, but smaller than SS (7.5, 7.5, 7.9 mm2,
p<0.01). In the LG group, these results were not different among 3 stent types.Conclusions: Real-time OCT revealed signiﬁcant acute recoil in the latest-generation
stents as well as conventional stents. For post-dilatation, multiple short inﬂations may
be better than single long inﬂation in optimizing the ﬁnal stent expansion.
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Background: The aim of this study was to evaluate the impact of stent design and
side branch access on ﬁnal strut apposition during bifurcation stenting.
Methods: 42 samples of 6 different commercially available Drug Eluting Stents
(DES) were deployed in an identical in-vitro coronary bifurcation model. The platform
tested were 16mm to 28mm in length and included the Everolimus eluting Xience V
(n¼9, Abbott Vascular, Santa Clara, CA), Promus Element (n¼9, Boston Scientiﬁc,
Natick, MA), the Paclitaxel eluting Taxus Liberte (n¼8, Boston Scientiﬁc, Natick,
MA), the Biolimus eluting Biomatrix Flex (n¼7, Biosensors International, Morges,
Switzerland), the Sirolimus eluting Cypher Select (n¼4, Cordis, Warren, NJ) and the
Zotaroliums eluting Resolute stents (n¼5), Medtronic, Santa Rosa, CA). Kissing
Balloon (KB) optimization was performed after either a proximal or a distal recrossing
of the guidewire and results were analyzed by Micro Computed-Tomography.
Results:When theSideBranch (SB)was accessed through amid-distal cell, average rates
of strut malapposition observed inside the bifurcation conﬂuence area remained low with
no signiﬁcant differences observed between the different platforms tested [15.4%-23.6%].
Conversely, proximal instead of distal cell recrossing toward the side branch producedmber 1, 2013 j TCT Abstracts/POSTER/Intravascular Imaging and PCI
